Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05515198 · ClinicalTrials.gov registry record · NA
Improving Care for Women With Urinary Incontinence (EMPOWER)
A NA study of Urinary Incontinence, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT05515198: Completed NA study of Urinary Incontinence, sponsored by University Hospitals Cleveland Medical Center.
NCT05515198 is a NA study of Urinary Incontinence that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 400 participants, above the 254-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (57% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05515198, a NA study of Urinary Incontinence, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal is to improve diagnosis and non-operative management of urinary incontinence in women.
Primary Outcome
The International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) assess frequency, severity and impact on quality of life (QoL) of patients' urinary incontinence symptoms. The result of the ICIQ-UI SF is a composite score ranging from 0 to 21, with higher scores indicating more severe incontinence.
Conditions Studied
Interventions
- OTHER Patient Education
- OTHER Nurse Navigation
- OTHER ChatBot
Study Locations (1)
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2022-09-06 |
| Est. Completion | 2024-12-23 |
| Phase | NA |
What the finished NCT05515198 record still lists
NCT05515198 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 254-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (57% higher).
The record links to 1 condition, with Urinary Incontinence appearing as the primary indexed condition, and to 3 interventions - of which Patient Education is the first listed.
NCT05515198 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05515198 about?
NCT05515198 is a clinical study titled "Improving Care for Women With Urinary Incontinence (EMPOWER)". The overall goal is to improve diagnosis and non-operative management of urinary incontinence in women.
What is the current status of trial NCT05515198?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2022-09-06. Estimated completion is 2024-12-23.
What conditions does trial NCT05515198 study?
This clinical trial studies the following conditions: Urinary Incontinence.
What interventions are being tested in trial NCT05515198?
The interventions under investigation include: Patient Education (OTHER), Nurse Navigation (OTHER), ChatBot (OTHER).
Who is sponsoring clinical trial NCT05515198?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05515198 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05515198's enrollment target sits among peer trials
400 9th of 48 higher than 40 of 48 other Urinary Incontinence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Incontinence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
-
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
RECRUITING · NA
-
Improving Overactive Bladder Treatment Access and Adherence
RECRUITING · NA
-
Training for Urinary Leakage Improvement After Pregnancy
RECRUITING · NA
-
Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI